Usana Health Sciences, Inc., a Utah-based nutritional, skincare and dietary products manufacturer, indicates in its recently filed 8-K that it has substantially completed an internal investigation into whether the expense reimbursement policy and other practices at its Chinese affiliate, BabyCare Ltd., were compliant with the Foreign Corrupt Practices Act. The company reports that it is cooperating with the DOJ and the SEC in their investigations of the matter.
February 5, 2019
DOJ and SEC investigating nutritional supplement maker for possible FCPA violations
Related by Topic
New Post
Connecticut oil and gas trader charged with FCPA violations for allegedly bribing Petrobras officials
September 4, 2023
News Alert
DOJ issues first FCPA Opinion Procedure Release of 2023
August 30, 2023
News Alert
US manufacturer pays $6.5 million to settle FCPA books and records violations
August 25, 2023
News Alert